| Size & multiples | |||
| Market Cap | $226.4M | Enterprise Value | $588.9M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.35× | P/FCF | 6.00× |
| EV/EBITDA | 28.41× | EV/EBIT | — |
| EV/Sales | 0.90× | EV/FCF | 15.60× |
| FCF Yield | 16.68% | Buyback Yield | — |
| Owner Earnings (TTM) | -$121.8M | Owner Earnings Yield | −53.82% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.28 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 10.40% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −3.33% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows latest annual · EPS TTM -$0.38 · revenue TTM $655.8M · FCF TTM $37.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on EV/EBITDA
EV/EBITDA 80th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| EV/EBITDA | 28.4x | 15.1x | 9.8x–24.4x | 80 ↑rich |
| FCF Yield | 16.7% | -7.8% | -34.7%–1.4% | 97 ↑strong |
| Net Margin | -20.6% | -21.2% | -325.3%–7.2% | 50 ↑strong |
| Operating Margin | -4.3% | -34.5% | -552.0%–8.0% | 64 ↑strong |
| ROE | -33.2% | -36.8% | -92.5%–4.5% | 52 ↑strong |
